SCHEMBL9998346

SCHEMBL9998346

CC(=O)OC(OC(C)=O)C(=Cc1cccc(C(C)(C)C)c1)Cc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP26A1 O43174 1/20 0.41
CYP26B1 Q9NR63 1/20 0.41
TSHR P16473 1/20 0.40
NR1H4 Q96RI1 2/20 0.38
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
ALDH1A1 P00352 1/20 0.36
BCHE P06276 2/20 0.36
TRPV1 Q8NER1 1/20 0.36
KCNH2 Q12809 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
MRGPRX4 Q96LA9 1/20 0.35
ACHE P22303 2/20 0.35
RXRA P19793 2/20 0.34
RXRB P28702 2/20 0.34
RXRG P48443 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998345 1.00 CYP26A1 (0.41) CYP26A1CYP26B1TSHRNR1H4CYP3A4
SCHEMBL9998138 0.86 ALDH1A1 (0.44) TSHRNR1H4CYP3A4CYP2C9ALDH1A1
SCHEMBL9998140 0.86 ALDH1A1 (0.44) TSHRNR1H4CYP3A4CYP2C9ALDH1A1
SCHEMBL9998245 0.85 TRPV1 (0.38) CYP26A1CYP26B1NR1H4TRPV1KCNH2
SCHEMBL9998244 0.85 TRPV1 (0.38) CYP26A1CYP26B1NR1H4TRPV1KCNH2
SCHEMBL9998023 0.85 CYP3A4 (0.50) TSHRNR1H4CYP3A4CYP2C9ALDH1A1
SCHEMBL9998025 0.85 CYP3A4 (0.50) TSHRNR1H4CYP3A4CYP2C9ALDH1A1
SCHEMBL9997839 0.84 TSHR (0.42) TSHRCYP3A4CYP2C9ALDH1A1
SCHEMBL9997711 0.84 TSHR (0.42) TSHRCYP3A4CYP2C9ALDH1A1CYP1A2
SCHEMBL9997837 0.84 TSHR (0.42) TSHRCYP3A4CYP2C9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 CYP26A1 265/4885CYP26B1 241/4885TSHR 621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.